Goodwill (Details) - USD ($) |
12 Months Ended | |||
|---|---|---|---|---|
Oct. 31, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Oct. 20, 2023 |
|
| Goodwill [Line Items] | ||||
| Goodwill | $ 1,795,406 | $ 1,795,406 | $ 1,795,406 | $ 1,795,406 |
| Deferred liability | 1,110,000 | |||
| Investment in subsidiary asset value | $ 424,593 | $ 424,593 | ||
| Deferred liability in subsidiary | $ 85,000 | $ 1,018,000 | ||
| Common stock, shares issued | 89,348,478 | 89,348,478 | ||
| Shares issued at signing | 1,500,000 | |||
| Shares issued at future date | 150,000 | |||
| Additional paid in capital | $ 1,110,000 | |||
| Deferred liability in subsidiary | $ 35,700 | $ 121,500 | ||
| Forecast horizon term | 5 years | |||
| Gain From Deferred Liability of Subsidiary | $ 85,000 | $ 1,018,000 | ||
| Impairment | ||||
| Weighted average cost of capital | 24.60% | |||
| Goodwill [Member] | ||||
| Goodwill [Line Items] | ||||
| Goodwill | $ 2,220,000 | |||
| Estimated fair value of reporting unit | $ 8,240,000 | |||
| Transport US Inc [Member] | ||||
| Goodwill [Line Items] | ||||
| Goodwill | 424,593 | |||
| Value shares | $ 2,220,000 | |||
| AGSS shares [Member] | ||||
| Goodwill [Line Items] | ||||
| Common stock, shares issued | 3,000,000 |
| X | ||||||||||
- Definition The amount of decrease in deferred liability subsidiary. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Forecast horizon term. No definition available.
|
| X | ||||||||||
- Definition The amount of gain from deferred liability of subsidiary. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The percentage of weighted average cost capital. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued at future date. No definition available.
|
| X | ||||||||||
- Definition The shares issued at signing. No definition available.
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income during the current period and current obligations not separately disclosed in the balance sheet (other liabilities, current). No definition available.
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after tax, of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of additional paid-in capital (APIC) classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of fair value of reporting unit in excess of carrying amount. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|